Search
Barbexaclone
go.drugbank.com/drugs/DB09001ExperimentalThese reports were conducted in a small series of patients in the 1970s and 1980s, and have yet to be confirmed by larger controlled trials. … With this difference in potency in mind, other pharmacokinetic considerations such as dose titration, daily dosing, and optimal plasma concentration can be considered the same as for the equivalent amount
Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 InducersCystic fibrosis transmembrane conductance regulator
go.drugbank.com/drugs/DB15180InvestigationalCystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis).
Categories: Ion Pumps, Ion ChannelsSulfate ion
go.drugbank.com/drugs/DB14546InvestigationalSynonyms: Sulfuric acid ion(2-), Sulfate ionMixtures: Telom-X-gene, VAMIN 14 IV AMINOASIT SOLÜSYONU, 500 MLINKP-102
go.drugbank.com/drugs/DB05326ExperimentalINKP-102 is the next generation sodium phosphate tablet designed to aid bowl preparation before colonoscopy.
Madecassoside
go.drugbank.com/drugs/DB15532InvestigationalSynonyms: Asiaticoside AMixtures: Karatica Im Cica Essence PackNickel cation
go.drugbank.com/drugs/DB14204InvestigationalSynonyms: Nickel ion(2+), Nickel(2+) ionMixtures: BIOGROW MINPhenoxybenzamine
go.drugbank.com/drugs/DB00925ApprovedInvestigationalAn alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Categories: Peripheral alpha-1 blockers, Adrenergic alpha-1 Receptor AntagonistsDiloxanide
go.drugbank.com/drugs/DB08792ExperimentalAlthough it is not currently approved for use in the United States, it was approved by a CDC study in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990. … Diloxanide (as [Diloxanide furoate]) is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections.
Categories: Heterocyclic Compounds, 1-RingTecadenoson
go.drugbank.com/drugs/DB04954InvestigationalTecadenoson is a novel selective A1 adenosine receptor agonist that is currently being evaluated for the conversion of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. … It is being developed by CV Therapeutics, Inc.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring